Razumab 2.3mg Injection

Razumab 2.3mg Injection

Here you'll find essential details about Razumab 2.3mg Injection, a Intas Pharmaceuticals Ltd product containing the salt combination Ranibizumab (2.3mg). Key uses of this medication include Diabetic eye disease,Wet age-related macular degeneration,Macular edema due to retinal vein occlusion. Take a moment to explore the specific information provided in the 'Detail' section and utilize the wishlist and compare features for a better understanding.

Information about Razumab 2.3mg Injection (Brand: Intas Pharmaceuticals Ltd) - Uses: Diabetic eye disease,Wet age-related macular degeneration,Macular edema due to retinal vein occlusion

Wishlist Add to cart

  • MRP: ₹ 17000
  • Packing: 1.0 Injection in 1 vial
  • Salt Combination: Ranibizumab (2.3mg)
  • Brand: Intas Pharmaceuticals Ltd
  • Uses: Diabetic eye disease,Wet age-related macular degeneration,Macular edema due to retinal vein occlusion

Description

  • Razumab 2.3mg Injection is used for the treatment of eye diseases which are caused by diabetes, macular degeneration, and macular swelling
  • It reduces the abnormal growth and leakage of blood vessels in the eye that can cause vision loss
  • Razumab 2.3mg Injection is administered directly into the eyeball by an eye specialist
  • You should not self administer this medicine at home.
  • The common side effects include conjunctival hemorrhage, eye pain, eye floaters, increased intraocular pressure, and eye inflammation
  • If these side effects get worse or persist for a longer duration, inform your doctor
  • It is not advised to drive after administration of this injection as it may cause temporary blurring of vision.
  • There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg
  • Please contact your prescribing doctor to know more about the same
  • You may also call on (1800-102-1618) for more details.

Cautions

Liver: SAFE IF PRESCRIBED: Razumab 2.3mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Razumab 2.3mg Injection may not be needed in these patients. Please consult your doctor.
Kidney: SAFE IF PRESCRIBED: Razumab 2.3mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Razumab 2.3mg Injection may not be needed in these patients. Please consult your doctor.
Driving: UNSAFE: Razumab 2.3mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Breast feeding: SAFE IF PRESCRIBED: Razumab 2.3mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnency: CONSULT YOUR DOCTOR: Razumab 2.3mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol: CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Razumab 2.3mg Injection. Please consult your doctor.
Drug Action: Vascular endothelial growth factor (VEGF) inhibitor for AMD
Therapeutic class: OPHTHAL
Habit Forming: No
Chemical Class: Monoclonal antibody (mAb)

Uses

Uses of Razumab 2.3mg Injection

  • Diabetic eye disease Wet age-related macular degeneration Macular edema due to retinal vein occlusion
Missed Doses
If you miss a dose of Razumab 2.3mg Injection, please consult your doctor.

FAQs

Frequestly asked Questions

Side Effects

Common and Known Side effects of Razumab 2.3mg Injection
  • Conjunctival hemorrhage
  • Eye pain
  • Increased intraocular pressure
  • Foreign body sensation in eyes
  • Blurred vision
  • Nausea
  • Dry eye
  • Eye itching
  • Cataract
  • Vitreous floaters
  • Vitreous detachment
  • Intraocular inflammation
  • Eye irritation
  • Increased lacrimation
  • Eyelid inflammation
  • Ocular hyperemia
  • Retinal disorder
  • Maculopathy
  • Eye discomfort
  • Posterior capsule opacification
  • Injection site hemorrhage
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Anemia (low number of red blood cells)
  • Joint pain
  • Renal failure
  • Peripheral neuropathy (tingling and numbness of feet and hand)
  • Gastro-esophageal reflux disease
  • Hypercholesterolemia (high cholesterol)
  • Bronchitis (inflammation of the airways)

Reviews

Add your review




Alternate Medicines


No Product Found